IL10, interleukin 10, 3586

N. diseases: 1679; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE These results suggest that IL-10 released by mesenchymal cells in inflammatory arthritis can modulate synovial inflammation and joint destruction by paracrine and/or autocrine mechanisms. 11327238 2001
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE To gain insight into IL-10 responses in inflammatory arthritis, we used microarray analysis to determine the patterns of IL-10-inducible gene expression in freshly isolated RA and seronegative SpA synovial macrophages. 16947381 2006
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 AlteredExpression disease BEFREE Increment in the level of IL-10 in the combination group could be positively correlated with the recovery of arthritis. 28326455 2017
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE In this study, we demonstrated that anti-inflammatory cytokine IL-10 was a critical mediator for PGRN-mediated anti-inflammation in collagen-induced arthritis by using PGRN and IL-10 genetically modified mouse models. 28011648 2017
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 AlteredExpression disease BEFREE A single intraperitoneal injection of human IL-10 expression plasmid complexed with liposomes 2 to 4 days after the onset of arthritis was sufficient to give significant and prolonged amelioration of arthritis for 30 days. 10849557 2000
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 AlteredExpression disease BEFREE These data indicate that local over-expression of IL-10 in the knee joint of mice regulates the expression of collagen arthritis, probably through down-regulation of TNF-alpha. 10792391 2000
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE Interleukin-10 (IL-10) produced by butyrate-induced expanded T<sub>reg</sub> cells was critical, as treatment with butyrate did not affect inflammatory arthritis in IL-10-knockout mice. 30034392 2018
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE Efficacy of interleukin-10 gene electrotransfer into skeletal muscle in mice with collagen-induced arthritis. 12539154 2003
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 AlteredExpression disease BEFREE In addition, administration of PF (5, 10 and 20 mg/kg/day) for 28 days markedly exhibited an anti-arthritic activity by offsetting the body weight loss, inhibiting the paw edema, reducing the arthritis scores and the indices of thymus and spleen, inhibiting the expression levels of TNF-α, IL-1β, IL-6, COX-2 and 5-LOX, and increasing the expression of IL-10, when compared with the respective control group in CFA-induced arthritis assay. 28352356 2017
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE Finally, we showed a strong correlation between APRIL and IL-10 in the inflamed synovial tissue of inflammatory arthritis patients. 31258536 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE Our previous work showed that under inflammatory condition MZ B-cells differentiated into IL-10 producing cells and contributed to the downregulation of collagen-induced arthritis, while follicular B-cells failed to do so. 31216428 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE APL-2, an altered peptide ligand derived from heat-shock protein 60, induces interleukin-10 in peripheral blood mononuclear cell derived from juvenile idiopathic arthritis patients and downregulates the inflammatory response in collagen-induced arthritis model. 24474501 2015
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE Conversely, Sm infection did not affect the exacerbated arthritis in IL-10 KO mice, although IL-17A production was reduced by the helminth. 30194773 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 GeneticVariation disease BEFREE Furthermore, we show that injection of an adenoviral vector carrying the IL-10 gene into a single paw can suppress development of arthritis in other, noninjected paws of the same individual. 10092823 1999
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 AlteredExpression disease BEFREE These results suggest that TOV has significant anti-arthritic effects on collagen-induced arthritis in rats, which may be attributed to the inhibition of the levels of IL-1β, IL-6, IL-8, IL-17A, TNF-α, MMP-3 and MMP-9, and the increase of IL-10 in serum as well as down-regulation of the protein expression of COX-2 and iNOS in synovial tissues via suppressing the phosphorylation and degradation of IκB. 30831463 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE Our data identify a novel role for FoxO1 in regulating IL-10 secretion during classic activation and highlight the potential for therapeutic interventions for chronic inflammatory conditions, such as atherosclerosis, diabetes, inflammatory bowel disease, and arthritis. 25420919 2015
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE Our work demonstrated that EEC possessed the potential therapeutic effect against arthritis in rodents which was attributed to modulating proinflammatory cytokines TNF-α, IL-1β and anti-inflammatory factors IL-10. 29753098 2018
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 AlteredExpression disease BEFREE Human, viral or mutant human IL-10 expressed after local adenovirus-mediated gene transfer are equally effective in ameliorating disease pathology in a rabbit knee model of antigen-induced arthritis. 16704745 2006
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE These results suggest that IL-10 limits the development of joint inflammation in both arthritis-resistant and -susceptible mouse strains infected with B. burgdorferi and that increased IL-10 production cannot rescue genetic susceptibility to development of pathology in this model. 18824530 2008
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer. 10640777 2000
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE Disease-dependent local IL-10 production ameliorates collagen induced arthritis in mice. 23166758 2012
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 GeneticVariation disease BEFREE Individuals with IL-10 receptor mutations also experience cutaneous folliculitis and arthritis. 25004811 2014
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 GeneticVariation disease BEFREE To determine the distribution of the interleukin-10 (IL-10) 5' flanking region haplotypes in children with arthritis and in controls, and to investigate the functional significance of each haplotype. 10366102 1999
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE DBA/1 mice doubly deficient in IL-4 and IL-10 were used to confirm that these two cytokines are important for the APL-induced attenuation of arthritis. 27837109 2016
CUI: C0003864
Disease: Arthritis
Arthritis
0.200 Biomarker disease BEFREE IL-17 deficiency ameliorated disease symptoms of inflammatory arthritis in IL-1RaKO mice by suppressing the frequency of plasma cells and antibody production while enhancing the frequency of IL-10-producing B cells. 29803636 2018